BR9804995A - Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos - Google Patents

Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos

Info

Publication number
BR9804995A
BR9804995A BR9804995-0A BR9804995A BR9804995A BR 9804995 A BR9804995 A BR 9804995A BR 9804995 A BR9804995 A BR 9804995A BR 9804995 A BR9804995 A BR 9804995A
Authority
BR
Brazil
Prior art keywords
medicine
same
pharmaceutical preparations
ring compounds
sulfonamide
Prior art date
Application number
BR9804995-0A
Other languages
English (en)
Inventor
Joaquim Dr Brendel
Uwe Dr Gerlach
Hans Jochen Dr Lang
Klaus Dr Weidmann
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR9804995A publication Critical patent/BR9804995A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS DE ANEL DE 5 MEMBROS FUNDIDO SUBSTITUìDOS COM SULFONAMIDA, SEU USO COMO MEDICAMENTO E PREPARAçõES FARMACêUTICAS COMPREENDENDO OS MESMOS"<D>. Compostos da fórmula I tendo os significados dos substituintes indicados nas reivindicações são substâncias extraordinariamente ativas para a produção de medicamentos para a profilaxia e para a terapia de distúrbios cardiovasculares, em particular arritmias, para o tratamento de úlceras da região gastrintestinal ou para o tratamento de doenças diarréicas.
BR9804995-0A 1997-11-10 1998-11-10 Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos BR9804995A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19749453A DE19749453A1 (de) 1997-11-10 1997-11-10 Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
BR9804995A true BR9804995A (pt) 2001-05-22

Family

ID=7848065

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804995-0A BR9804995A (pt) 1997-11-10 1998-11-10 Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos

Country Status (29)

Country Link
US (1) US6015822A (pt)
EP (1) EP0915087B1 (pt)
JP (1) JP4331809B2 (pt)
KR (1) KR19990045147A (pt)
CN (1) CN1219533A (pt)
AR (1) AR016006A1 (pt)
AT (1) ATE236120T1 (pt)
AU (1) AU742199B2 (pt)
BR (1) BR9804995A (pt)
CA (1) CA2253211C (pt)
CZ (1) CZ363798A3 (pt)
DE (2) DE19749453A1 (pt)
DK (1) DK0915087T3 (pt)
ES (1) ES2196456T3 (pt)
HR (1) HRP980585B1 (pt)
HU (1) HUP9802590A3 (pt)
ID (1) ID21282A (pt)
IL (1) IL126955A (pt)
MY (1) MY115619A (pt)
NO (1) NO312546B1 (pt)
NZ (1) NZ332633A (pt)
PL (1) PL329596A1 (pt)
PT (1) PT915087E (pt)
RU (1) RU2223951C2 (pt)
SI (1) SI0915087T1 (pt)
SK (1) SK283866B6 (pt)
TR (1) TR199802270A2 (pt)
TW (1) TW427970B (pt)
ZA (1) ZA9810202B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332943C (zh) 1998-07-08 2007-08-22 萨诺费－阿文蒂斯德国有限公司 硫取代的磺酰基氨基羧酸n－芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP1240147A1 (en) 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
WO2003053954A1 (en) * 2001-12-12 2003-07-03 F. Hoffmann-La Roche Ag Benzothiophenes as adenosine receptor modulators
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
KR101126895B1 (ko) * 2006-01-24 2012-03-20 일라이 릴리 앤드 캄파니 프로게스테론 수용체의 인돌 술폰아미드 조절제
JP2009026126A (ja) * 2007-07-20 2009-02-05 Nec Electronics Corp 半導体装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910003337B1 (ko) * 1983-03-04 1991-05-27 오오쓰까세이야꾸 가부시끼가이샤 인단 유도체 및 그 염의 제조방법
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
JPH11236368A (ja) 1999-08-31
DE59807718D1 (de) 2003-05-08
DE19749453A1 (de) 1999-05-12
NO985171L (no) 1999-05-11
CZ363798A3 (cs) 1999-05-12
RU2223951C2 (ru) 2004-02-20
EP0915087A2 (de) 1999-05-12
HRP980585A2 (en) 1999-06-30
PT915087E (pt) 2003-08-29
TR199802270A2 (xx) 1999-05-21
EP0915087B1 (de) 2003-04-02
HU9802590D0 (en) 1999-01-28
JP4331809B2 (ja) 2009-09-16
EP0915087A3 (de) 1999-07-21
ATE236120T1 (de) 2003-04-15
CA2253211A1 (en) 1999-05-10
DK0915087T3 (da) 2003-07-21
SI0915087T1 (en) 2003-10-31
HUP9802590A3 (en) 2001-08-28
NO312546B1 (no) 2002-05-27
ZA9810202B (en) 1999-05-10
IL126955A0 (en) 1999-09-22
CA2253211C (en) 2009-04-14
SK154598A3 (en) 1999-06-11
AU742199B2 (en) 2001-12-20
US6015822A (en) 2000-01-18
SK283866B6 (sk) 2004-03-02
TW427970B (en) 2001-04-01
CN1219533A (zh) 1999-06-16
ES2196456T3 (es) 2003-12-16
HUP9802590A2 (hu) 2000-04-28
KR19990045147A (ko) 1999-06-25
ID21282A (id) 1999-05-12
PL329596A1 (en) 1999-05-24
AR016006A1 (es) 2001-05-30
AU9139898A (en) 1999-05-27
NZ332633A (en) 2000-05-26
IL126955A (en) 2002-11-10
NO985171D0 (no) 1998-11-05
HRP980585B1 (en) 2003-02-28
MY115619A (en) 2003-07-31

Similar Documents

Publication Publication Date Title
HUP0001442A2 (hu) Szulfonamidszármazékok és ezeket tartalmazó gyógyászati készítmények endotelin átal közvetített betegségek kezelésére
ES2145913T3 (es) Inhibidores de metaloproteasas.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
NO890075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
BR9107124A (pt) Novos derivados de acido hidroxamico e de n-hidroxiureia e seu uso
BR9711098B1 (pt) compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
DE3686483D1 (de) Arzneimittel.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
PT806952E (pt) Antagonistas da progesterona para a preparacao de medicamentos para o tratamento de hemorragias uterinas disfuncionais
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
BR0007514A (pt) Macrolìdeos com atividade anti-inflamatória
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
BR9803367A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
RU93044489A (ru) Производные хиноксалина, их получение, лекарственные средства на их основе
BR9804995A (pt) Compostos de anel de 5 membros fundido substituìdos com sulfonamida, seu uso como medicamento e preparações farmacêuticas compreendendo os mesmos
BRPI0107493B8 (pt) substâncias para uso no tratamento de psoríase
BR9803233A (pt) Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares.
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
BR0115883A (pt) Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor
FR2680172B1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
BR9803974A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos
BR9803739A (pt) Compostos substituìdos por sulfonamida, processos para sua preparação, seu uso como medicamento ou diagnóstico, e medicamento que os contém.

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007.